Fig. 1From: Efficacy and safety of evogliptin in the treatment of type 2 diabetes mellitus in a Brazilian population: a randomized bridging studyDisposition of subjects in study groups and populations. EVO evogliptin, FPG fasting plasma glucose, ITT intention-to-treat, PP per protocol, qd once-daily, SITA sitagliptinBack to article page